Please Wait.....
Report
Global Autoinjectors Market, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), By Design (Standardized v/s Customized), By Product (Prefilled v/s Fillable), By Technology (Automated v/s Manual), By Type (Disposable v/s Reusable), By Route of Administration (Intravenous v/s Subcutaneous), By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings), By Region, Competition Forecast & Opportunities, 2027
Market Report I 2022-07-01 I 115 Pages I TechSci Research
The global autoinjectors market is expected to witness a growth of robust CAGR in the forecast period, 2023-2027. Factors such as increased incidence of anaphylaxis and availability of generic autoinjectors in the market are primarily driving the demand for the global autoinjectors market. The rise in the prevalence of targeted therapies and the shift in preference of consumers for self-administration of drugs are expected to further fuel the market demand in the forecast period. Also, the massive government support and favorable reimbursements and advancements in the healthcare industry are expected to create numerous growth opportunities for the market players in the next five years.
The global autoinjectors market is segmented into therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitive landscape. Based on therapy, the market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others. The rheumatoid arthritis segment is expected to capture the highest market share in the forecast period, 2023-2027. The high prevalence of rheumatoid arthritis worldwide is expected to drive the demand for autoinjectors across the globe.
The major market players in the global autoinjectors market are Mylan N.V., AbbVie Inc., Eli Lilly and Company, Ypsomed Holding AG, Amgen Inc., Becton, Dickinson, and Company, GlaxoSmithKline plc, Johnson & Johnson International, Inc., Teva Pharmaceutical Industries Ltd., Antares Pharma, Inc., Merck KGaA, F. Hoffmann-LA Roche, Bayer AG, Bristol-Myers Squibb Company, and Medeca Pharma AB.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze the historical growth in the market size of global autoinjectors market from 2017 to 2021.
- To estimate and forecast the market size of global autoinjectors market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast global autoinjectors market based on therapy, design, product, technology, type, route of administration, end user, regional distribution, and competitional landscape.
- To identify dominant region or segment in the global autoinjectors market.
- To identify drivers and challenges for global autoinjectors market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global autoinjectors market.
- To identify and analyze the profile of leading players operating in global autoinjectors market.
- To identify key sustainable strategies adopted by market players in global autoinjectors market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of global autoinjectors market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Manufacturers, end users, and other stakeholders
- Distributers and suppliers of autoinjectors and other stakeholders
- Organizations, forums, and alliances related to autoinjectors market
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global autoinjectors market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Autoinjectors Market, By Therapy:
o Rheumatoid Arthritis
o Multiple Sclerosis
o Diabetes
o Anaphylaxis
o Others
- Global Autoinjectors Market, By Design:
o Standardized
o Customized
- Global Autoinjectors Market, By Product:
o Prefilled
o Fillable
- Global Autoinjectors Market, By Technology:
o Automated
o Manual
- Global Autoinjectors Market, By Type:
o Disposable
o Reusable
- Global Autoinjectors Market, By Route of Administrations:
o Intravenous
o Subcutaneous
- Global Autoinjectors Market, By End User:
o Hospitals & Clinics
o Ambulatory Care Settings
o Home Care Settings
- Global Autoinjectors Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
o Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
o South America
- Brazil
- Argentina
- Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global autoinjectors market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Impact of COVID-19 on Global Autoinjectors Market
6. Global Autoinjectors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others)
6.2.2. By Design (Standardized v/s Customized)
6.2.3. By Product (Prefilled v/s Fillable)
6.2.4. By Technology (Automated v/s Manual)
6.2.5. By Type (Disposable v/s Reusable)
6.2.6. By Route of Administration (Intravenous v/s Subcutaneous)
6.2.7. By End User (Hospitals & Clinics, Ambulatory Care Settings, Home Care Settings)
6.2.8. By Company (2021)
6.2.9. By Region
6.3. Product Market Map
7. Asia-Pacific Autoinjectors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy
7.2.2. By Design
7.2.3. By Product
7.2.4. By Technology
7.2.5. By Type
7.2.6. By Route of Administration
7.2.7. By End User
7.2.8. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Autoinjectors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy
7.3.1.2.2. By Design
7.3.1.2.3. By Product
7.3.1.2.4. By Technology
7.3.1.2.5. By Type
7.3.1.2.6. By Route of Administration
7.3.1.2.7. By End User
7.3.2. India Autoinjectors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy
7.3.2.2.2. By Design
7.3.2.2.3. By Product
7.3.2.2.4. By Technology
7.3.2.2.5. By Type
7.3.2.2.6. By Route of Administration
7.3.2.2.7. By End User
7.3.3. South Korea Autoinjectors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy
7.3.3.2.2. By Design
7.3.3.2.3. By Product
7.3.3.2.4. By Technology
7.3.3.2.5. By Type
7.3.3.2.6. By Route of Administration
7.3.3.2.7. By End User
7.3.4. Japan Autoinjectors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy
7.3.4.2.2. By Design
7.3.4.2.3. By Product
7.3.4.2.4. By Technology
7.3.4.2.5. By Type
7.3.4.2.6. By Route of Administration
7.3.4.2.7. By End User
7.3.5. Australia Autoinjectors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy
7.3.5.2.2. By Design
7.3.5.2.3. By Product
7.3.5.2.4. By Technology
7.3.5.2.5. By Type
7.3.5.2.6. By Route of Administration
7.3.5.2.7. By End User
8. Europe Autoinjectors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy
8.2.2. By Design
8.2.3. By Product
8.2.4. By Technology
8.2.5. By Type
8.2.6. By Route of Administration
8.2.7. By End User
8.2.8. By Country
8.3. Europe: Country Analysis
8.3.1. France Autoinjectors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy
8.3.1.2.2. By Design
8.3.1.2.3. By Product
8.3.1.2.4. By Technology
8.3.1.2.5. By Type
8.3.1.2.6. By Route of Administration
8.3.1.2.7. By End User
8.3.2. Germany Autoinjectors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy
8.3.2.2.2. By Design
8.3.2.2.3. By Product
8.3.2.2.4. By Technology
8.3.2.2.5. By Type
8.3.2.2.6. By Route of Administration
8.3.2.2.7. By End User
8.3.3. United Kingdom Autoinjectors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy
8.3.3.2.2. By Design
8.3.3.2.3. By Product
8.3.3.2.4. By Technology
8.3.3.2.5. By Type
8.3.3.2.6. By Route of Administration
8.3.3.2.7. By End User
8.3.4. Italy Autoinjectors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy
8.3.4.2.2. By Design
8.3.4.2.3. By Product
8.3.4.2.4. By Technology
8.3.4.2.5. By Type
8.3.4.2.6. By Route of Administration
8.3.4.2.7. By End User
8.3.5. Spain Autoinjectors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy
8.3.5.2.2. By Design
8.3.5.2.3. By Product
8.3.5.2.4. By Technology
8.3.5.2.5. By Type
8.3.5.2.6. By Route of Administration
8.3.5.2.7. By End User
9. North America Autoinjectors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy
9.2.2. By Design
9.2.3. By Product
9.2.4. By Technology
9.2.5. By Type
9.2.6. By Route of Administration
9.2.7. By End User
9.2.8. By Country
9.3. North America: Country Analysis
9.3.1. United States Autoinjectors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy
9.3.1.2.2. By Design
9.3.1.2.3. By Product
9.3.1.2.4. By Technology
9.3.1.2.5. By Type
9.3.1.2.6. By Route of Administration
9.3.1.2.7. By End User
9.3.2. Mexico Autoinjectors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy
9.3.2.2.2. By Design
9.3.2.2.3. By Product
9.3.2.2.4. By Technology
9.3.2.2.5. By Type
9.3.2.2.6. By Route of Administration
9.3.2.2.7. By End User
9.3.3. Canada Autoinjectors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy
9.3.3.2.2. By Design
9.3.3.2.3. By Product
9.3.3.2.4. By Technology
9.3.3.2.5. By Type
9.3.3.2.6. By Route of Administration
9.3.3.2.7. By End User
10. South America Autoinjectors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy
10.2.2. By Design
10.2.3. By Product
10.2.4. By Technology
10.2.5. By Type
10.2.6. By Route of Administration
10.2.7. By End User
10.2.8. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Autoinjectors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy
10.3.1.2.2. By Design
10.3.1.2.3. By Product
10.3.1.2.4. By Technology
10.3.1.2.5. By Type
10.3.1.2.6. By Route of Administration
10.3.1.2.7. By End User
10.3.2. Argentina Autoinjectors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy
10.3.2.2.2. By Design
10.3.2.2.3. By Product
10.3.2.2.4. By Technology
10.3.2.2.5. By Type
10.3.2.2.6. By Route of Administration
10.3.2.2.7. By End User
10.3.3. Colombia Autoinjectors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy
10.3.3.2.2. By Design
10.3.3.2.3. By Product
10.3.3.2.4. By Technology
10.3.3.2.5. By Type
10.3.3.2.6. By Route of Administration
10.3.3.2.7. By End User
11. Middle East and Africa Autoinjectors Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapy
11.2.2. By Design
11.2.3. By Product
11.2.4. By Technology
11.2.5. By Type
11.2.6. By Route of Administration
11.2.7. By End User
11.2.8. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Autoinjectors Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapy
11.3.1.2.2. By Design
11.3.1.2.3. By Product
11.3.1.2.4. By Technology
11.3.1.2.5. By Type
11.3.1.2.6. By Route of Administration
11.3.1.2.7. By End User
11.3.2. Saudi Arabia Autoinjectors Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapy
11.3.2.2.2. By Design
11.3.2.2.3. By Product
11.3.2.2.4. By Technology
11.3.2.2.5. By Type
11.3.2.2.6. By Route of Administration
11.3.2.2.7. By End User
11.3.3. UAE Autoinjectors Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapy
11.3.3.2.2. By Design
11.3.3.2.3. By Product
11.3.3.2.4. By Technology
11.3.3.2.5. By Type
11.3.3.2.6. By Route of Administration
11.3.3.2.7. By End User
11.3.4. Kuwait Autoinjectors Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Therapy
11.3.4.2.2. By Design
11.3.4.2.3. By Product
11.3.4.2.4. By Technology
11.3.4.2.5. By Type
11.3.4.2.6. By Route of Administration
11.3.4.2.7. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Mylan N.V.
14.2. AbbVie Inc.
14.3. Eli Lilly and Company
14.4. Ypsomed Holding AG
14.5. Amgen Inc.
14.6. Becton, Dickinson, and Company
14.7. GlaxoSmithKline plc
14.8. Johnson & Johnson International, Inc.
14.9. Teva Pharmaceutical Industries Ltd
14.10. Antares Pharma, Inc.
14.11. Merck KGaA
14.12. F. Hoffmann-LA Roche
14.13. Bayer AG
14.14. Bristol-Myers Squibb Company
14.15. Medeca Pharma AB
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security